The Medicines (Cyanogenetic Substances) Order 1984

• Citation: S.I. 1984/187
• Sections: 2

Section 1 Citation, commencement and interpretation

(1) This order may be cited as the Medicines (Cyanogenetic Substances) Order 1984 and shall come into operation on the tenth day after the day on which it is made.

(2) In this order—

“ the Act ” means the Medicines Act 1968;

“ cyanogenetic substances ” means preparations which—

are presented for sale or supply under the name of, or as containing, amygdalin, laetrile or vitamin B17 or

contain more than 0.1 per cent by weight of any substance having the formula either α-Cyanobenzyl-6-O-Β-D-glucopyranosyl-Β-D-glucopyranoside or α-Cyanobenzyl-Β-D-glucopyranosiduronic acid.

Section 2 Application of specified provisions of the Act

For the purposes of section 104(1) of the Act, cyanogenetic substances which are intended for human consumption and are not manufactured, sold, supplied, imported or exported wholly or mainly in either of the ways specified in section 130(1) of the Act are hereby specified as substances which appear to the Health Ministers to be substances which are not medicinal products but which are manufactured, sold, supplied, imported or exported for use wholly or partly for a medicinal purpose and it is hereby directed that the provisions contained in Part I, sections 51, 52, 55(1), 57, 58, 61 to 67, 85 to 88, 91 to 93, 95 and 97 and Part VIII of the Act shall have effect in relation to such substances as those provisions have effect in relation to medicinal products.